← All companies

OMER

Omeros Corporation

OMER Nasdaq Pharmaceutical Preparations EDGAR ↗

$12.56

+0.72 +6.08%

Key statistics

from XBRL data in SEC filings

Market cap

$909M

Revenue (TTM)

$73.8M

Net income (TTM)

$86.2M

EPS (TTM)

$1.15

P/E ratio

10.9

Dividend yield

—

Free cash flow

-$116M

Cash

$1.91M

Total assets

$286M

Gross margin

—

52-week range

$3.61 – $17.65

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 20, 2026 8-K Other events Jul 6, 2026 8-K Shareholder vote results Jun 25, 2026 8-K Other events Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Results of operations (earnings release) Jan 7, 2026 8-K Other events Dec 29, 2025 8-K Terminated a material agreement; Completed an acquisition or disposition; Other events Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Other events Oct 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Other events Jul 25, 2025 8-K Shareholder vote results Jul 2, 2025 8-K/A FORM 8-K/A May 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Other events May 15, 2025 8-K Other events May 6, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Other events Feb 20, 2025 8-K Other events Jan 16, 2025 8-K Other events Dec 19, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change; Shareholder vote results Jun 12, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure; Other events Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Results of operations (earnings release) Apr 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation Feb 7, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023